On ECHEMI
Home > Drugs > Persistent cholestatic jaundice of the newborn
Persistent cholestatic jaundice of the newborn
Infant cholestasis refers to a persistent reduction in infant bile secretion due to liver cell damage and/or intrahepatic and extrahepatic bile duct obstruction. The main clinical manifestations are hyperconjugated hyperbilirubinemia [i.e., blood direct bilirubin >25.5µmol/L (1.5mg/dl), or direct-to-total bile duct ratio >20%], hepatosplenomegaly, abnormal liver function, and fat malabsorption. Some people call this syndrome infantile hepatitis syndrome, but since the cases included do not all have pathological changes of hepatitis, this name deserves further discussion. This article mainly discusses cholestasis that occurs within 3 months after birth.
  • Site of disease:

    Skin Liver
  • Infectious :

    Not contagious
  • Frequent population:

    Infants under 1 year old
  • Related symptoms:

    Fetal growth retardation loss of appetite edema baby feeding difficulties grey stool
  • Concurrent disease:

Related Drugs
Bile Betel Nut Vitamin B1 Capsules
Indication: It is used for various constipations and abdominal pain, loss of appetite, etc. caused by gastrointestinal dysfunction due to abdominal inflammation, intestinal adhesions, hepatobiliary diseases, etc.
Manufacturer:

Zhengzhou Ruilong Pharmaceutical Co., Ltd.

Huangbo Capsule
Manufacturer:

Hunan Fangsheng Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.